Agency for Science, Technology and Research logo
Singapore Therapeutics Development Review

STDR Pre-Pilot (Q1/Q3 cycles)

Funds early-stage therapeutic proof-of-concept research in Singapore across multiple modalities.

ClosedAgency for Science, Technology and ResearchSingapore
View on funder site
About

The Singapore Therapeutics Development Review (STDR) Pre-Pilot track is an A*STAR grant funding earlier-stage, exploratory proof-of-concept therapeutic research with awards of up to S$325,000. The programme supports two research streams: target validation and platform development. Eligible modalities include small molecules, large molecules, cell and gene therapies, and platform technologies. Call…

What this grant funds

Earlier-stage proof-of-concept therapeutics: target validation and platform development. Small molecules, large molecules, cell and gene therapies, platform technologies.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Where founders trip up

Sign up free to see where teams trip up

Create free accountSign in
Last verified: 22 Jul 2026Source: www.a-star.edu.sg